LifeGlue Technologies has been selected among the Top 30 startups to compete in the highly competitive sTARTUp Pitching 2026 competition, taking place at sTARTUp Day in Tartu, Estonia.
The pitching competition attracted a strong international applicant pool, with only 30 startups advancing through a rigorous pre-selection process. LifeGlue Technologies was chosen to pitch its clinically oriented Glue4Life bioink platform to an international audience of investors and ecosystem leaders.
CEO Laura Kuittinen will take the stage on January 29, 2026, at the Estonian National Museum, presenting LifeGlue Tech's vision of becoming the foundational bioink platform enabling the clinical manufacturing of human tissues.
More information about the event is available at www.startupday.ee/